Refinement of an Established Procedure and Its Application for Identification of Hypoxia in Prostate Cancer Xenografts

The authors designed a dissection method for validating the use of a 15-gene hypoxia classifier, which was previously established for head and neck squamous cell carcinoma patients, to identify hypoxia in prostate cancer.